Literature DB >> 22470725

FDG PET/CT diagnosis of hepatic lymphoma mimicking focal fatty infiltration on CT.

Eugene Lin1, Marie Lee, Nicholas Agoff.   

Abstract

Areas of hypoattenuation in the liver which do not have mass effect are typically thought to represent focal fatty infiltration. Rarely, tumors can present without mass effect in the liver. We present a case in which areas of liver hypoattenuation which were initially thought to represent focal fatty infiltration on CT due to lack of mass effect had abnormal uptake on a FDG PET/CT exam; these areas were due to secondary hepatic involvement from non-Hodgkin's lymphoma.

Entities:  

Keywords:  Liver; Lymphoma; PET; Positron Emission Tomography

Year:  2010        PMID： 22470725      PMCID： PMC3303388          DOI： 10.3941/jrcr.v4i4.374

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN： 1943-0922


  24 in total

1.  Utility of FDG-PET scanning in lymphoma by WHO classification.

Authors:  Rebecca Elstrom; Liang Guan; Gary Baker; Khozaim Nakhoda; Jo-Anne Vergilio; Hongming Zhuang; Stephanie Pitsilos; Adam Bagg; Lisa Downs; Amit Mehrotra; Scott Kim; Abass Alavi; Stephen J Schuster
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

2.  Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults.

Authors:  B F Kammen; P Pacharn; R F Thoeni; Y Lu; A Qayyum; F Coakly; C A Gooding; R C Brasch
Journal:  AJR Am J Roentgenol       Date:  2001-11       Impact factor: 3.959

3.  Imaging findings in pancreatic lymphoma: differential aspects.

Authors:  E M Merkle; G N Bender; H J Brambs
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

4.  Non-hodgkin's lymphoma of the liver in patients with AIDS: sonographic, CT, and MRI findings.

Authors:  E B Rizzi; V Schinina; M Cristofaro; V David; C Bibbolino
Journal:  J Clin Ultrasound       Date:  2001 Mar-Apr       Impact factor: 0.910

5.  Positron emission tomography/computed tomography in the diagnosis of multifocal primary hepatic lymphoma.

Authors:  Winnie K S Chan; Eric W C Tse; Yuen-Shan Fan; Jingbo Zhang; Yok-Lam Kwong; Pek-Lan Khong
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

6.  Diagnosis of liver involvement by lymphoma: results in 96 consecutive peritoneoscopies.

Authors:  C M Bagley; L B Thomas; R E Johnson; P B Chretien; V T DeVita
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

7.  Usefulness of FDG-PET in diagnosing primary lymphoma of the liver.

Authors:  M Bangerter; F Moog; M Griesshammer; E Merkle; M Hafner; V Ellenrieder; S N Reske; H Heimpel
Journal:  Int J Hematol       Date:  1997-12       Impact factor: 2.490

8.  Imaging of primary non-Hodgkin's lymphoma of the liver.

Authors:  M M Maher; S R McDermott; H M Fenlon; D Conroy; J C O'Keane; D N Carney; J P Stack
Journal:  Clin Radiol       Date:  2001-04       Impact factor: 2.350

9.  Non-Hodgkin lymphoma of the gastrointestinal tract.

Authors:  C Smith; R A Kubicka; C R Thomas
Journal:  Radiographics       Date:  1992-09       Impact factor: 5.333

Review 10.  NCCN task force: clinical utility of PET in a variety of tumor types.

Authors:  Donald A Podoloff; Douglas W Ball; Edgar Ben-Josef; Al B Benson; Steven J Cohen; R Edward Coleman; Dominique Delbeke; Maria Ho; David H Ilson; Gregory P Kalemkerian; Richard J Lee; Jay S Loeffler; Homer A Macapinlac; Robert J Morgan; Barry Alan Siegel; Seema Singhal; Douglas S Tyler; Richard J Wong
Journal:  J Natl Compr Canc Netw       Date:  2009-06       Impact factor: 11.908
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.